RNA, U6 small nuclear 1207, pseudogene (RNU6-1207P)

RNA, U6 small nuclear 1207, pseudogene (RNU6-1207P) is a processed pseudogene of the U6 small nuclear RNA (snRNA) gene in humans. U6 snRNA is a highly conserved component of the spliceosome, playing a central role in pre-mRNA splicing by catalyzing intron removal from precursor mRNAs. However, RNU6-1207P is not an active gene; it is a non-functional genomic sequence generated by retrotransposition, lacking the necessary regulatory elements or structure to be involved in spliceosome function or gene regulation. Pseudogenes like RNU6-1207P do not encode functional RNA or protein and are not recognized as receptors, enzymes, or traditional drug targets. There is no evidence that this pseudogene has roles in disease, drug interactions, or serves as a biomarker. U6 small nuclear RNAs are core spliceosomal RNAs, but the pseudogene forms (including RNU6-1207P) arise through retrotransposition mechanisms and are mostly "genomic fossils" without current biological function. The locus type is explicitly listed as "pseudogene". RNU6 pseudogenes are numerous in the genome; their presence is used to study retrotransposition dynamics but not as therapeutic or diagnostic entities. There is no evidence in the literature that RNU6-1207P, or similar pseudogenes, are involved in pathology or targeted therapeutically. RNU6-1207P is not a therapeutic target, not a biologically active RNA, and does not have clinical roles. There is nothing intrinsically wrong with the gene symbol, but this entity should not be considered a drug target or marker.

Other names

RNU6-1207PU6 snRNA pseudogene 1207